Pancreatic malignancy portends poor prognosis with a dismal 5-year survival of 8%. 1 Moreover, the disease burden of pancreatic cancer continues to rise, having the second highest incidence among gastrointestinal tumors in the U.S. 2 Prompt tissue diagnosis allows for early targeted treatment, potentially improving progression-free survival. 3 The advent of endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) and endoscopic ultrasound-guided fine needle biopsy (EUS-FNB) has permitted minimally invasive tissue acquisition for tissue diagnosis. Unlike FNA needles, the reverse or opposing cutting bevel design of the FNB needle allows for the biopsy of core histopathologic tissue. 4 EUS-FNA and EUS-FNB provide accurate diagnoses of solid pancreatic lesions with a reported sensitivity of 85% and 87%, respectively. 5,6 Previous studies comparing the two needles have yielded conflicting results with no clear superiority. 7-10 There has been a recent increase in randomized con
Video 1 Resection of a subepithelial duodenal lesion using band-assisted endoscopic full-thickness resection using full-thickness resection device.▶ Fig. 1 Duodenal lesion after banding and creation of a "pseudo-polyp" (left). Resected lesion showing intact bands (right).
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.